-
First Mesothelioma Patient Dosed With ISM6331 in Clinical Trial
05 Feb 2025 16:23 GMT
… shows benefits in clinical trials.
This drug works by stopping mesothelioma cells from … a Chinese mesothelioma patient in the ongoing phase I clinical trial.
“We look … diagnosis
Recommending clinical trials that could work for you
At Mesothelioma Hope, we …
-
Mesothelioma Market Size to Reach USD 972.0 Million by 2035, Impelled by Advancements in Diagnostic Technologies
04 Feb 2025 23:22 GMT
… this challenging cancer.
Revolutionizing Mesothelioma Treatment: The Rise of … molecular underpinnings of mesothelioma. Therefore, treatment for mesothelioma is becoming increasingly … of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and …
-
Oligometastatic Disease Market to Expand Significantly by 2034, States DelveInsight Report
05 Feb 2025 17:56 GMT
… , Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company focused on … . 2022, are lung cancer and mesothelioma (29%), skin cancer (20%), … treatment market, visit @ Oligometastatic Disease Clinical Trials and Therapeutic Assessment
Table of …
-
Immunotherapeutic responses and their assessments
04 Feb 2025 23:25 GMT
… and 12.5% in mesothelioma. [5]
Clinical implications for atypical responses … irRC, irRECIST and imRECIST in clinical trial protocols, and subsequent inconsistencies … consider integrative endpoints. [7]
Several clinical trials with immune therapeutics rely on …
-
Neurofibromatosis Type 2 Market is set for steady growth, with a robust CAGR anticipated by 2034, estimates DelveInsight
04 Feb 2025 11:49 GMT
… III POPLAR-Neurofibromatosis Type 2 clinical trial was announced at the … in patients with advanced malignant mesothelioma and tumors associated with Neurofibromatosis … field. @ Neurofibromatosis Type 2 Ongoing Clinical Trials- https://www.delveinsight …
-
Addicted: How the World Got Hooked on Illicit Drugs – And Why We Need to View This as a Global Threat Like Climate Change
04 Feb 2025 11:53 GMT
… Obstructive Pulmonary Disease FDA Approvals, Clinical Trials, Pipeline Insights, Emerging Drugs, … for New Energy Projects
Florida Mesothelioma Victims Center Recommends the … Current or Former Electrician with Mesothelioma or Lung Cancer in …
-
Improving Cancer Outcomes By Backing Our Researchers
03 Feb 2025 19:24 GMT
… key protein interactions to treat mesothelioma – Dr J Troung, RMIT
Taking … helping to improve early detection, clinical trials, or innovative, lifesaving new treatments …
-
Innovative Cancer Treatments: How Medical Advancements is Changing Lives
31 Jan 2025 16:49 GMT
… the advancements in immunotherapy is mesothelioma immunotherapy, which offers hope to … it quite hard to treat. Mesothelioma immunotherapy involves the use of … still under evaluation in several clinical trials for various cancers.
Cancer vaccines …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma
31 Jan 2025 12:21 GMT
… patients with unresectable malignant pleural mesothelioma (MPM).
OPDIVO® (nivolumab), … and Dexamethasone
In randomized clinical trials in patients with multiple … previously untreated unresectable malignant pleural mesothelioma, in combination with YERVOY; …
-
Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer
05 Feb 2025 07:15 GMT
… inform their broader implications for clinical practice and healthcare policy.
Abbreviations … use for unresectable malignant pleural mesothelioma. https://www.optunelua … open-label, multicentre randomised controlled trial. Lancet. 2017;389(10066):255 …
About
© 1995-2025